Checkpoint inhibitors: What gastroenterologists need to know
Checkpoint inhibitors are increasingly being used in clinical practice. They can cause various gastrointestinal, hepatic and pancreatic side effects. As these side effects can be serious, appropriate management is essential. The different checkpoint inhibitors with their mechanisms of action and ind...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319137/ https://www.ncbi.nlm.nih.gov/pubmed/30622372 http://dx.doi.org/10.3748/wjg.v24.i48.5433 |
_version_ | 1783385021779804160 |
---|---|
author | Ahmed, Monjur |
author_facet | Ahmed, Monjur |
author_sort | Ahmed, Monjur |
collection | PubMed |
description | Checkpoint inhibitors are increasingly being used in clinical practice. They can cause various gastrointestinal, hepatic and pancreatic side effects. As these side effects can be serious, appropriate management is essential. The different checkpoint inhibitors with their mechanisms of action and indications, as well as evaluation and management of gastrointestinal, hepatic and pancreatic side effects, are discussed in this article. |
format | Online Article Text |
id | pubmed-6319137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-63191372019-01-08 Checkpoint inhibitors: What gastroenterologists need to know Ahmed, Monjur World J Gastroenterol Minireviews Checkpoint inhibitors are increasingly being used in clinical practice. They can cause various gastrointestinal, hepatic and pancreatic side effects. As these side effects can be serious, appropriate management is essential. The different checkpoint inhibitors with their mechanisms of action and indications, as well as evaluation and management of gastrointestinal, hepatic and pancreatic side effects, are discussed in this article. Baishideng Publishing Group Inc 2018-12-28 2018-12-28 /pmc/articles/PMC6319137/ /pubmed/30622372 http://dx.doi.org/10.3748/wjg.v24.i48.5433 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Ahmed, Monjur Checkpoint inhibitors: What gastroenterologists need to know |
title | Checkpoint inhibitors: What gastroenterologists need to know |
title_full | Checkpoint inhibitors: What gastroenterologists need to know |
title_fullStr | Checkpoint inhibitors: What gastroenterologists need to know |
title_full_unstemmed | Checkpoint inhibitors: What gastroenterologists need to know |
title_short | Checkpoint inhibitors: What gastroenterologists need to know |
title_sort | checkpoint inhibitors: what gastroenterologists need to know |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319137/ https://www.ncbi.nlm.nih.gov/pubmed/30622372 http://dx.doi.org/10.3748/wjg.v24.i48.5433 |
work_keys_str_mv | AT ahmedmonjur checkpointinhibitorswhatgastroenterologistsneedtoknow |